EUVIMEDEUVIMED entdecken
Crossref

Gprc5a is a novel parathyroid hormone‐inducible gene and negatively regulates osteoblast proliferation and differentiation

Chisato Sampei, Kosuke Kato, Yasuhiro Arasaki, Yuta Kimura, Takuto Konno, Kanon Otsuka, Yukihiro Kohara, Masaki Noda, Yoichi Ezura iD, Tadayoshi Hayata iD

Journal of Cellular Physiology · 2024

DOI: 10.1002/jcp.31297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Chisato Sampei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Science, Tokyo University of Science, …. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Osteoblasts, Cell Differentiation, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Teriparatide is a peptide derived from a parathyroid hormone (PTH) and an osteoporosis therapeutic drug with potent bone formation‐promoting activity. To identify novel druggable genes that act downstream of PTH signaling and are potentially involved in bone formation, we screened PTH target genes in mouse osteoblast‐like MC3T3‐E1 cells. Here we show that Gprc5a , encoding an orphan G protein‐coupled receptor, is a novel PTH‐inducible gene and negatively regulates osteoblast proliferation and differentiation. PTH treatment induced Gprc5a expression in MC3T3‐E1 cells, rat osteosarcoma ROS17/2.8 cells, and mouse femurs. Induction of Gprc5a expression by PTH occurred in the absence of protein synthesis and was mediated primarily via the cAMP pathway, suggesting that Gprc5a is a direct target of PTH signaling. Interestingly, Gprc5a expression was induced additively by co‐treatment with PTH and 1α, 25‐dihydroxyvitamin D3 (calcitriol), or retinoic acid in MC3T3‐E1 cells. Reporter analysis of a 1 kb fragment of human GPRC5A promoter revealed that the promoter fragment showed responsiveness to PTH via the cAMP response element, suggesting that GPRC5A is also a PTH‐inducible gene in humans. Gprc5a knockdown promoted cell viability and proliferation, as demonstrated by MTT and BrdU assays. Gprc5a knockdown also promoted osteoblast differentiation, as indicated by gene expression analysis and mineralization assay. Mechanistic studies showed that Gprc5a interacted with BMPR1A and suppressed BMP signaling induced by BMP‐2 and constitutively active BMP receptors, ALK2 (ACVR1) Q207D and ALK3 (BMPR1A) Q233D. Thus, our results suggest that Gprc5a is a novel gene induced by PTH that acts in an inhibitory manner on both cell proliferation and osteoblast differentiation and is a candidate for drug targets for osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledOsteoblastsCell DifferentiationCell ProliferationParathyroid HormoneAnimalsMiceRatsHumansSignal TransductionOsteogenesisPromoter Regions, GeneticBone Morphogenetic Protein 2Cyclic AMPTretinoinCalcitriol

Stichwörter der Autor:innen

Gprc5aMC3T3‐E1osteoblastosteoporosisparathyroid hormone (PTH)teriparatide

Substanzen

Receptors, G-Protein-CoupledParathyroid HormoneGPRC5A protein, mouseGPRC5A protein, humanBone Morphogenetic Protein 2Cyclic AMPTretinoinCalcitriol

Autor:innen und Institutionen

  • Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Science, Tokyo University of Science, Noda, Chiba, Japan.
  • Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Bunkyo-ku, Tokyo, Japan.
  • Center for Stem Cell and Regenerative Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Department of Joint Surgery and Sports Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Department of Occupational Therapy, Faculty of Health and Medical Science, Teikyo Heisei University, Toshima-ku, Japan.

ORCID-Profile: Yoichi Ezura, Tadayoshi Hayata

Förderung

  • JSPS KAKENHI

Zitieren

APA

Sampei, C., Kato, K., Arasaki, Y., Kimura, Y., Konno, T., Otsuka, K., Kohara, Y., Noda, M., Ezura, Y., & Hayata, T. (2024). Gprc5a is a novel parathyroid hormone‐inducible gene and negatively regulates osteoblast proliferation and differentiation. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31297

Vancouver

Sampei C, Kato K, Arasaki Y, Kimura Y, Konno T, Otsuka K, et al. Gprc5a is a novel parathyroid hormone‐inducible gene and negatively regulates osteoblast proliferation and differentiation. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31297

BibTeX
@article{Sampei2024,
  author = {Sampei, Chisato and Kato, Kosuke and Arasaki, Yasuhiro and Kimura, Yuta and Konno, Takuto and Otsuka, Kanon and Kohara, Yukihiro and Noda, Masaki and Ezura, Yoichi and Hayata, Tadayoshi},
  title = {Gprc5a is a novel parathyroid hormone‐inducible gene and negatively regulates osteoblast proliferation and differentiation},
  journal = {Journal of Cellular Physiology},
  year = {2024},
  doi = {10.1002/jcp.31297}
}
Kostenlos starten →